Vesicare | Solifenacin Succinate 160 Mg Breastfeeding

American Academy of Pediatrics and other medical experts exclusively recommend to breastfeed the baby for first 6 months. Once you introduce baby to other foods it is recommended to breastfeed for at least first year of babys life. Taking medication while breastfeeding could be tricky as most drugs pass in breast milk. In this article we will evaluate Vesicare | Solifenacin Succinate 160 Mg for its safety in breastfeeding.

What is Vesicare | Solifenacin Succinate 160 Mg used for?


VESIcare is a muscarinic antagonist indicated for the treatment of overactive bladder with symptoms of urge urinary incontinence, urgency, and urinary frequency. VESIcare is a muscarinic antagonist indicated for the treatment of overactive bladder with symptoms of urge urinary incontinence, urgency, and urinary frequency (1)

What are the risk associated with Vesicare | Solifenacin Succinate 160 Mg usage while breastfeeding? What precautions shall I take while using it in breastfeeding?

Vesicare | Solifenacin Succinate 160 Mg high risk while breastfeeding
As Vesicare | Solifenacin Succinate 160 Mg is made of only Solifenacin succinate, and Solifenacin succinate is unsafe to use in breastfeeding we can safely reach on conclusion that Vesicare | Solifenacin Succinate 160 Mg is also unsafe to use while breastfeeding. Below is detailed analysis of Solifenacin succinate and Vesicare | Solifenacin Succinate 160 Mg during location. We recommend you to go through provided detailed analysis as below take decision accordingly. We also recommend you talk to your health care provider before making final decision.

Statement of Manufacturer/Labeler about breastfeeding usage
8.3 Nursing Mothers After oral administration of 14C-solifenacin succinate to lactating mice, radioactivity was detected in maternal milk. There were no adverse observations in mice treated with 1.2 times (30 mg/kg/day) the expected exposure at the maximum recommended human dose [MRHD]. Pups of female mice treated with 3.6 times (100 mg/kg/day) the exposure at the MRHD or greater revealed reduced body weights, postpartum pup mortality or delays in the onset of reflex and physical development during the lactation period. It is not known whether solifenacin is excreted in human milk. Because many drugs are excreted in human milk, VESIcare should not be administered during nursing. A decision should be made whether to discontinue nursing or to discontinue VESIcare in nursing mothers.

Vesicare | Solifenacin Succinate 160 Mg Breastfeeding Analsys


Solifenacin succinate while Breastfeeding

Unsafe

Advice to take a minimal dose for a short time since anti-cholinergic drugs may decrease breast milk production. Check-up for anti-cholinergic symptoms (mouth dryness, constipation...)


Vesicare | Solifenacin Succinate 160 Mg Breastfeeding Analsys - 2


Solifenacin succinate while Breastfeeding

CAS Number: 242478-37-1

Because there is no published experience with solifenacin during breastfeeding and it has a long half-life averaging 55 hours, an alternate drug may be preferred, especially while nursing a newborn or preterm infant. Long-term use of solifenacin might reduce milk production or milk letdown. During long-term use, observe the infant for signs of decreased milk production (e.g., insatiety, poor weight gain) and for anticholinergic symptoms (e.g., constipation, urinary retention, UTI, dry mouth).


Is Vesicare | Solifenacin Succinate 160 Mg safe while breastfeeding

I already used Vesicare | Solifenacin Succinate 160 Mg and meanwhile I breastfed my baby should I be concerned?

If you observer abnormal behavior or any other health issue in infant then you should immediately call 911 or contact other contact other emergency service provider in your area otherwise closely monitor the baby and inform your doctor about your Vesicare | Solifenacin Succinate 160 Mg usage and time interval of breastfeeding.


I am nursing mother and my doctor has suggested me to use Vesicare | Solifenacin Succinate 160 Mg, is it safe?

If your doctor knows that you are breastfeeding mother and still prescribes Vesicare | Solifenacin Succinate 160 Mg then there must be good reason for that as Vesicare | Solifenacin Succinate 160 Mg is considered unsafe, It usually happens when doctor finds that overall advantage of taking outweighs the overall risk.


If I am using Vesicare | Solifenacin Succinate 160 Mg, will my baby need extra monitoring?

Yes, Extra monitoring is required if mother is using Vesicare | Solifenacin Succinate 160 Mg and breastfeeding as it is considered unsafe for baby.


Who can I talk to if I have questions about usage of Vesicare | Solifenacin Succinate 160 Mg in breastfeeding?

US
National Womens Health and Breastfeeding Helpline: 800-994-9662 (TDD 888-220-5446) 9 a.m. and 6 p.m. ET, Monday through Friday

UK
National Breastfeeding Helpline: 0300-100-0212 9.30am to 9.30pm, daily
Association of Breastfeeding Mothers: 0300-330-5453
La Leche League: 0345-120-2918
The Breastfeeding Network supporter line in Bengali and Sylheti: 0300-456-2421
National Childbirth Trust (NCT): 0300-330-0700

Australia
National Breastfeeding Helpline: 1800-686-268 24 hours a day, 7 days a week

Canada
Telehealth Ontario for breastfeeding: 1-866-797-0000 24 hours a day, 7 days a week